You are currently on the new version of our website. Access the old version .

149 Results Found

  • Article
  • Open Access
1 Citations
1,676 Views
11 Pages

Serotonin-Mediated Anti-Allodynic Effect of Yokukansan on Diabetes-Induced Neuropathic Pain

  • Yoko Kajikawa,
  • Hiroshi Yokomi,
  • Soshi Narasaki,
  • Satoshi Kamiya,
  • Hirotsugu Miyoshi,
  • Takahiro Kato and
  • Yasuo M. Tsutsumi

22 July 2024

Background: Diabetic neuropathic pain is a known complication of diabetes mellitus (DM) and results from the complex interaction of various factors affecting the nervous system. Yokuansan (YKS) is a versatile traditional Japanese herbal medicine with...

  • Article
  • Open Access
3 Citations
5,161 Views
22 Pages

Guanfacine Normalizes the Overexpression of Presynaptic α-2A Adrenoceptor Signaling and Ameliorates Neuropathic Pain in a Chronic Animal Model of Type 1 Diabetes

  • Neha Munawar,
  • Joelle Nader,
  • Najat H. Khadadah,
  • Ashraf Al Madhoun,
  • Waleed Al-Ali,
  • Linu A. Varghese,
  • Willias Masocha,
  • Fahd Al-Mulla and
  • Milad S. Bitar

Background: Diabetes is associated with several complications, including neuropathic pain, which is difficult to manage with currently available drugs. Descending noradrenergic neurons possess antinociceptive activity; however, their involvement in d...

  • Article
  • Open Access
4 Citations
13,406 Views
12 Pages

Effects of Short-Term Treatment with α-Lipoic Acid on Neuropathic Pain and Biomarkers of DNA Damage in Patients with Diabetes Mellitus

  • Juozas R. Lazutka,
  • Kristina Daniūnaitė,
  • Veronika Dedonytė,
  • Aistė Popandopula,
  • Karolina Žukaitė,
  • Žydrūnė Visockienė and
  • Laura Šiaulienė

16 November 2024

Background/Objectives: Diabetes mellitus (DM) is a complex and heterogenous disease classified as a group of metabolic disorders characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. It leads to...

  • Review
  • Open Access
12 Citations
4,472 Views
13 Pages

Diabetic neuropathic pain (DNP) is one of the common and severe late-stage complications of diabetes mellitus, which could greatly influence the patients’ quality of life. Patients with DNP often experience spontaneous pain and evoked pain such...

  • Article
  • Open Access
11 Citations
3,344 Views
17 Pages

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats

  • Nazarine Mokhtar,
  • Marcin Drop,
  • Florian Jacquot,
  • Sylvain Lamoine,
  • Eric Chapuy,
  • Laetitia Prival,
  • Youssef Aissouni,
  • Vittorio Canale,
  • Frédéric Lamaty and
  • Christine Courteix
  • + 3 authors

15 February 2023

Diabetic neuropathy is often associated with chronic pain. Serotonin type 6 (5-HT6) receptor ligands, particularly inverse agonists, have strong analgesic potential and may be new candidates for treating diabetic neuropathic pain and associated co-mo...

  • Review
  • Open Access
1 Citations
5,340 Views
12 Pages

Perspectives on Stem Cell Therapy in Diabetic Neuropathic Pain

  • Tadeu Lima Montagnoli,
  • Aimeé Diogenes Santos,
  • Susumu Zapata Sudo,
  • Fernanda Gubert,
  • Juliana Ferreira Vasques,
  • Rosalia Mendez-Otero,
  • Mauro Paes Leme de Sá and
  • Gisele Zapata-Sudo

30 August 2024

Diabetes mellitus-related morbidity and mortality are primarily caused by long-term complications such as retinopathy, nephropathy, cardiomyopathy, and neuropathy. Diabetic neuropathy (DN) involves the progressive degeneration of axons and nerve fibe...

  • Article
  • Open Access
11 Citations
3,327 Views
13 Pages

Sleep Characteristics in Diabetic Patients Depending on the Occurrence of Neuropathic Pain and Related Factors

  • Cristina Naranjo,
  • María Dueñas,
  • Carlos Barrera,
  • Guillermo Moratalla and
  • Inmaculada Failde

This study aims to compare the sleep characteristics (structure and quality) in patients with type-2 diabetes mellitus with and without diabetic neuropathic pain (DNP), and to investigate the relationship of sensory phenotypes, anxiety, and depressio...

  • Article
  • Open Access
16 Citations
6,348 Views
18 Pages

8 November 2024

Glucagon-like peptide 1 (GLP-1) receptor agonists are frequently used to treat type 2 diabetes and obesity. Despite the development of several drugs for neuropathic pain management, their poor efficacy, tolerance, addiction potential, and side effect...

  • Article
  • Open Access
12 Citations
3,938 Views
17 Pages

Diabetic neuropathy (DN) causes sensory dysfunction, such as numbness, tingling, or burning sensations. Traditional medication may not ease pain and discomfort, but natural remedies such as Berberine (BR) and vitamin E or Tocopherol (TOC) have therap...

  • Article
  • Open Access
30 Citations
6,063 Views
15 Pages

Eruca sativa Meal against Diabetic Neuropathic Pain: An H2S-Mediated Effect of Glucoerucin

  • Elena Lucarini,
  • Eleonora Pagnotta,
  • Laura Micheli,
  • Carmen Parisio,
  • Lara Testai,
  • Alma Martelli,
  • Vincenzo Calderone,
  • Roberto Matteo,
  • Luca Lazzeri and
  • Carla Ghelardini
  • + 1 author

19 August 2019

The management of pain in patients affected by diabetic neuropathy still represents an unmet therapeutic need. Recent data highlighted the pain-relieving efficacy of glucosinolates deriving from Brassicaceae. The purpose of this study was to evaluate...

  • Systematic Review
  • Open Access
3 Citations
7,187 Views
23 Pages

Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis

  • Juan José Valenzuela-Fuenzalida,
  • Michelle López-Chaparro,
  • Marisol Barahona-Vásquez,
  • Javiera Campos-Valdes,
  • Javiera Cordero Gonzalez,
  • Pablo Nova-Baeza,
  • Mathias Orellana-Donoso,
  • Alejandra Suazo-Santibañez,
  • Gustavo Oyanedel-Amaro and
  • Héctor Gutiérrez Espinoza

Objectives: Diabetic peripheral neuropathy (DPN) is a chronic complication of diabetes mellitus (DM) with symptoms like intense pain and impaired quality of life. This condition has no treatment; instead, the pain is managed with various antidepressa...

  • Article
  • Open Access
13 Citations
3,660 Views
22 Pages

20 September 2023

Neuropathic pain is a well-documented phenomenon in experimental and clinical diabetes; however, current treatment is unsatisfactory. Serotoninergic-containing neurons are key components of the descending autoinhibitory pathway, and a decrease in the...

  • Article
  • Open Access
8 Citations
6,189 Views
15 Pages

Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems

  • Mustafa Burak Barbaros,
  • Özgür Devrim Can,
  • Umut İrfan Üçel,
  • Nazlı Turan Yücel and
  • Ümide Demir Özkay

19 August 2018

Atomoxetine is a selective noradrenaline reuptake inhibitor drug. Based on the knowledge that agents increasing monoamine levels in the central nervous system have therapeutic potential for neuropathic pain, it is planned to investigate the possible...

  • Article
  • Open Access
5 Citations
3,354 Views
18 Pages

Catecholaminergic and Cholinergic Systems Mediate Beneficial Effect of Vortioxetine on Diabetes-Induced Neuropathic Pain

  • Nazlı Turan Yücel,
  • Ümmühan Kandemir,
  • Umut İrfan Üçel,
  • Ümide Demir Özkay and
  • Özgür Devrim Can

The therapeutic potential of vortioxetine on mechanical hyperalgesia/allodynia was investigated in rats with streptozotocin-induced diabetes, and its possible mechanism of action was elucidated in this study. The obtained findings demonstrated that s...

  • Article
  • Open Access
621 Views
12 Pages

Comparison of Intraneural FacilitationTM Therapy and Exercise on Patients with Type 2 Diabetes: A Single-Blind Randomized Trial

  • Kyan Sahba,
  • Christopher G. Wilson,
  • Evelen Gonzales,
  • Jamie Hankins,
  • Hailey Jahromi,
  • Mark Ghamsary and
  • Mark Bussell

Background: Diabetic peripheral neuropathy (DPN) is a prevalent complication of type 2 diabetes (T2D), associated with microvascular dysfunction and significant morbidity. Exercise is a cornerstone of diabetes care and has demonstrated benefits for n...

  • Case Report
  • Open Access
4 Citations
3,449 Views
10 Pages

Diabetic Neuropathic Cachexia: A Clinical Case and Review of Literature

  • Alessio Bellelli,
  • Daniele Santi,
  • Manuela Simoni and
  • Carla Greco

4 May 2022

A 46-year-old man was admitted to the surgical department because of abdominal pain and anemia, with the radiological finding of a perforated duodenal ulcer, and underwent laparoscopic surgical treatment. Type 2 diabetes mellitus (T2DM) had been diag...

  • Review
  • Open Access
8 Citations
10,733 Views
18 Pages

The Influence of Dietary Supplementations on Neuropathic Pain

  • Francesco D’Egidio,
  • Giorgia Lombardozzi,
  • Housem E. Kacem Ben Haj M’Barek,
  • Giada Mastroiacovo,
  • Margherita Alfonsetti and
  • Annamaria Cimini

27 July 2022

Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory nervous system and affects 7–10% of the worldwide population. Neuropathic pain can be induced by the use of drugs, including taxanes, thus triggering chemoth...

  • Perspective
  • Open Access
13 Citations
3,657 Views
8 Pages

Early Detection of Diabetic Peripheral Neuropathy by fMRI: An Evidence-Based Review

  • Ahish Chitneni,
  • Adam Rupp,
  • Joe Ghorayeb and
  • Alaa Abd-Elsayed

With the significant rise in the prevalence of diabetes worldwide, diabetic peripheral neuropathy (DPN) remains the most common complication among type 1 and 2 diabetics. The adverse sequelae of DPN, which include neuropathic pain, diabetic foot ulce...

  • Review
  • Open Access
7 Citations
4,165 Views
18 Pages

16 December 2024

Neuropathic pain is a complex and debilitating condition resulting from nerve damage, characterized by sensations such as burning, tingling, and shooting pain. It is often associated with conditions such as multiple sclerosis (MS), Guillain-Barr&eacu...

  • Article
  • Open Access
34 Citations
4,455 Views
17 Pages

Bergenin Reduces Experimental Painful Diabetic Neuropathy by Restoring Redox and Immune Homeostasis in the Nervous System

  • Cristiane F. Villarreal,
  • Dourivaldo S. Santos,
  • Pedro S. S. Lauria,
  • Kelly B. Gama,
  • Renan F. Espírito-Santo,
  • Paulo J. L. Juiz,
  • Clayton Q. Alves,
  • Jorge M. David and
  • Milena B. P. Soares

Diabetic neuropathy is a frequent complication of diabetes. Symptoms include neuropathic pain and sensory alterations—no effective treatments are currently available. This work characterized the therapeutic effect of bergenin in a mouse (C57/BL...

  • Review
  • Open Access
43 Citations
12,210 Views
18 Pages

Treatment of Painful Diabetic Neuropathy—A Narrative Review of Pharmacological and Interventional Approaches

  • Mayank Gupta,
  • Nebojsa Nick Knezevic,
  • Alaa Abd-Elsayed,
  • Mahoua Ray,
  • Kiran Patel and
  • Bhavika Chowdhury

Painful diabetic neuropathy (PDN) is a common complication of diabetes mellitus that is associated with a significant decline in quality of life. Like other painful neuropathic conditions, PDN is difficult to manage clinically, and a variety of pharm...

  • Review
  • Open Access
899 Views
23 Pages

Spinal Cord Stimulation in Painful Diabetic Neuropathy: Advances, Outcomes, and Future Directions

  • Roberto Gazzeri,
  • Jacopo Mosca,
  • Felice Occhigrossi,
  • Marcelo Galarza,
  • Riccardo Schiaffini,
  • Giustino Varrassi,
  • Marco Mercieri and
  • Matteo Luigi Giuseppe Leoni

12 December 2025

Painful diabetic neuropathy (PDN) is a common complication of diabetes mellitus, often inadequately managed by conventional pharmacological therapies. Alternative interventions, including spinal cord stimulation (SCS), have garnered increasing attent...

  • Review
  • Open Access
8 Citations
6,324 Views
12 Pages

Diabetic Neuropathic Pain and Serotonin: What Is New in the Last 15 Years?

  • Nazarine Mokhtar,
  • Stephane Doly and
  • Christine Courteix

The neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) is involved in numerous physiological functions and plays a key role in pain modulation including neuropathic pain. Diabetic neuropathy is a common complication of diabetes mellitus often acc...

  • Article
  • Open Access
14 Citations
3,895 Views
16 Pages

Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy

  • Milena Ślęczkowska,
  • Rowida Almomani,
  • Margherita Marchi,
  • Bianca T. A. de Greef,
  • Maurice Sopacua,
  • Janneke G. J. Hoeijmakers,
  • Patrick Lindsey,
  • Erika Salvi,
  • Gidon J. Bönhof and
  • Monique M. Gerrits
  • + 6 authors

Neuropathic pain is common in diabetic peripheral neuropathy (DN), probably caused by pathogenic ion channel gene variants. Therefore, we performed molecular inversion probes-next generation sequencing of 5 transient receptor potential cation channel...

  • Article
  • Open Access
8 Citations
3,526 Views
23 Pages

A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model

  • Aleksandra Bober,
  • Anna Piotrowska,
  • Katarzyna Pawlik,
  • Katarzyna Ciapała,
  • Magdalena Maciuszek,
  • Wioletta Makuch and
  • Joanna Mika

The ligands of chemokine receptors 2 and 5 (CCR2 and CCR5, respectively) are associated with the pathomechanism of neuropathic pain development, but their role in painful diabetic neuropathy remains unclear. Therefore, the aim of our study was to exa...

  • Article
  • Open Access
13 Citations
4,160 Views
18 Pages

Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies

  • Rowida Almomani,
  • Maurice Sopacua,
  • Margherita Marchi,
  • Milena Ślęczkowska,
  • Patrick Lindsey,
  • Bianca T. A. de Greef,
  • Janneke G. J. Hoeijmakers,
  • Erika Salvi,
  • Ingemar S. J. Merkies and
  • on behalf of the PROPANE Study Group
  • + 14 authors

Neuropathic pain is a frequent feature of diabetic peripheral neuropathy (DPN) and small fiber neuropathy (SFN). Resolving the genetic architecture of these painful neuropathies will lead to better disease management strategies, counselling and inter...

  • Review
  • Open Access
2 Citations
2,116 Views
29 Pages

Diabetic neuropathy (DN) remains a major clinical burden, characterized by progressive sensory dysfunction, pain, and impaired quality of life. Despite the available symptomatic treatments, there is a pressing need for disease-modifying therapies. In...

  • Article
  • Open Access
17 Citations
6,538 Views
12 Pages

Clinical Experience of High Frequency and Low Frequency TENS in Treatment of Diabetic Neuropathic Pain in Russia

  • Mustafa Al-Zamil,
  • Inessa A. Minenko,
  • Natalia G. Kulikova,
  • Michael Alade,
  • Marina M. Petrova,
  • Elena A. Pronina,
  • Irina V. Romanova,
  • Ekaterina A. Narodova,
  • Regina F. Nasyrova and
  • Natalia A. Shnayder

28 January 2022

Background: Transcutaneous electrical nerve stimulation (TENS) is presently one of the main methods of treatment for neuropathic pain in type II diabetes mellitus. The discussion about which TENS frequency is more effective in the treatment of neurop...

  • Article
  • Open Access
1,043 Views
15 Pages

The Activities of Recombinant Botulinum Toxin A on Spared Nerve Injury-Induced Neuropathic Pain in a Diabetic Mice Model

  • Akinyemi Ademola Omoniyi,
  • Rasmus Eich Hammer,
  • Sabrina Josefsen,
  • Mette Richner,
  • Stephane Lezmi,
  • Christian Bjerggaard Vægter,
  • Mikhail Kalinichev,
  • Páll Karlsson and
  • Jens Randel Nyengaard

3 November 2025

Diabetic neuropathy is characterized by nerve damage and chronic neuropathic pain and lacks effective treatment. Botulinum neurotoxin type A (BoNT/A), a neurotoxin with established therapeutic use in neurological disorders, has emerged as a potential...

  • Article
  • Open Access
8 Citations
2,616 Views
17 Pages

Morphine (MOR) is a commonly prescribed drug for the treatment of moderate to severe diabetic neuropathic pain (DNP). However, long-term MOR treatment is limited by morphine analgesic tolerance (MAT). The activation of microglial cells and the releas...

  • Article
  • Open Access
2 Citations
2,787 Views
15 Pages

PnPP-15, a Synthetic Peptide Derived from a Toxin from Phoneutria nigriventer Spider Venom, Alleviates Diabetic Neuropathic Pain and Acts Synergistically with Pregabalin in Mice

  • Xavier Maia Mariano,
  • Luana Caroline de Assis Ferreira,
  • Camila Megale Almeida-Leite,
  • Célio José de Castro Junior and
  • Maria Elena de Lima

7 September 2023

Diabetic neuropathic pain is one of the complications that affect a wide variety of the diabetic population and is often difficult to treat. Only a small number of patients experience pain relief, which usually comes with onerous side effects and low...

  • Article
  • Open Access
36 Citations
3,895 Views
17 Pages

Silencing P2X7R Alleviates Diabetic Neuropathic Pain Involving TRPV1 via PKCε/P38MAPK/NF-κB Signaling Pathway in Rats

  • Lisha Chen,
  • Hongji Wang,
  • Juping Xing,
  • Xiangchao Shi,
  • Huan Huang,
  • Jiabao Huang and
  • Changshui Xu

16 November 2022

Transient receptor potential vanillic acid 1 (TRPV1) is an ion channel activated by heat and inflammatory factors involved in the development of various types of pain. The P2X7 receptor is in the P2X family and is associated with pain mediated by sat...

  • Article
  • Open Access
12 Citations
4,567 Views
16 Pages

16 August 2020

Lysophosphatidic acid (LPA) signaling is known to play key roles in the initiation and maintenance of various chronic pain models. Here we examined whether LPA signaling is also involved in diabetes-induced abnormal pain behaviors. The high-fat diet...

  • Article
  • Open Access
16 Citations
5,174 Views
15 Pages

Glycyrrhiza glabra, commonly known as liquorice, contains several bioactive compounds such as flavonoids, sterols, triterpene, and saponins; among which, glycyrrhizic acid, an oleanane-type saponin, is the most abundant component in liquorice root. D...

  • Article
  • Open Access
7 Citations
2,956 Views
14 Pages

Reversal of Neuralgia Effect of Beta Carotene in Streptozotocin-Associated Diabetic Neuropathic Pain in Female Zebrafish via Matrix Metalloprotease-13 Inhibition

  • Nallupillai Paramakrishnan,
  • Laxmikant Chavan,
  • Khian Giap Lim,
  • Yamunna Paramaswaran and
  • Arunachalam Muthuraman

22 January 2023

Beta carotene is a natural anti-oxidant agent, and it inhibits the matrix metalloprotease (MMP) activity. Diabetic neuropathic pain (DNP) is produced by cellular oxidative stress. The role of the beta carotene effect in diabetic neuropathic pain is n...

  • Article
  • Open Access
44 Citations
5,756 Views
18 Pages

Novel Mechanism for Memantine in Attenuating Diabetic Neuropathic Pain in Mice via Downregulating the Spinal HMGB1/TRL4/NF-kB Inflammatory Axis

  • Suliman Y. Alomar,
  • Rehab E. Abo El Gheit,
  • Eman T. Enan,
  • Khaled S. El-Bayoumi,
  • Mohamed Z. Shoaeir,
  • Amany Y. Elkazaz,
  • Sultan S. Al Thagfan,
  • Sawsan A. Zaitone and
  • Rehab M. El-Sayed

Diabetic neuropathic pain (DNP) is a common diabetic complication that currently lacks an efficient therapy. The aim of the current work was to uncover the anti-allodynic and neuroprotective effects of memantine in a model of mouse diabetic neuropath...

  • Article
  • Open Access
17 Citations
3,163 Views
18 Pages

Implication of lncRNA MSTRG.81401 in Hippocampal Pyroptosis Induced by P2X7 Receptor in Type 2 Diabetic Rats with Neuropathic Pain Combined with Depression

  • Ting Zhan,
  • Shanshan Tang,
  • Junpei Du,
  • Jingshuang Liu,
  • Bodong Yu,
  • Yuxin Yang,
  • Yuting Xie,
  • Yanting Qiu,
  • Guodong Li and
  • Yun Gao

18 January 2024

Major depressive disorder (MDD) is a common complication of diabetes and is often observed alongside diabetic neuropathic pain (DNP) as a comorbidity in diabetic patients. Long non-coding RNA (lncRNA) plays an important role in various pathophysiolog...

  • Article
  • Open Access
3 Citations
2,435 Views
13 Pages

24 November 2024

Background/Objectives: There is increasing evidence linking circulating neurotoxic lipids to the progression of chronic neuroinflammatory diseases in the peripheral and central nervous systems. Strategies to modify lipid profiles, such as docosahexae...

  • Article
  • Open Access
11 Citations
6,711 Views
13 Pages

Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy

  • Triantafyllos Didangelos,
  • Eleni Karlafti,
  • Evangelia Kotzakioulafi,
  • Parthena Giannoulaki,
  • Zisis Kontoninas,
  • Anastasia Kontana,
  • Polykarpos Evripidou,
  • Christos Savopoulos,
  • Andreas L. Birkenfeld and
  • Konstantinos Kantartzis

10 September 2024

Aim: To investigate the efficacy of Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), nicotinamide (9 mg), and minerals (Mg 30 mg, Zn...

  • Systematic Review
  • Open Access
17 Citations
4,598 Views
20 Pages

Spinal cord stimulation (SCS) is increasingly used to treat painful diabetic neuropathy (PDN). At the time of a recent meta-analysis in this field, data were only available from randomized controlled trials (RCTs) of traditional low-frequency SCS (LF...

  • Review
  • Open Access
29 Citations
8,671 Views
16 Pages

Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes

  • Sasha Smith,
  • Pasha Normahani,
  • Tristan Lane,
  • David Hohenschurz-Schmidt,
  • Nick Oliver and
  • Alun Huw Davies

19 July 2022

Distal symmetrical polyneuropathy (DSPN) is a serious complication of diabetes associated with significant disability and mortality. Although more than 50% of people with diabetes develop DSPN, its pathogenesis is still relatively unknown. This lack...

  • Systematic Review
  • Open Access
2,223 Views
21 Pages

Corneal Nerve Morphology in Painful Diabetic Neuropathy: A Meta-Analysis of In Vivo Confocal Microscopy Studies

  • Prajna Vidyasagar,
  • Scott F. Farrell,
  • Luisa Holguin Colorado,
  • Samantha Dando and
  • Katie Edwards

Background/Objectives: Painful diabetic peripheral neuropathy (pDPN) significantly impacts quality of life, yet its diagnosis remains challenging due to reliance on subjective pain reports and limited objective biomarkers. This meta-analysis evaluate...

  • Review
  • Open Access
5 Citations
2,540 Views
16 Pages

7 December 2024

Diabetes is a chronic and progressive disease associated with high blood glucose levels. Several co-morbidities arise from diabetes, the most common and severe one is diabetic neuropathy whose symptoms also include pain hypersensitivity. Currently, t...

  • Review
  • Open Access
96 Citations
13,027 Views
19 Pages

TRPA1 Antagonists for Pain Relief

  • Ari Koivisto,
  • Niina Jalava,
  • Raymond Bratty and
  • Antti Pertovaara

1 November 2018

Here, we review the literature assessing the role of transient receptor potential ankyrin 1 (TRPA1), a calcium-permeable non-selective cation channel, in various types of pain conditions. In the nervous system, TRPA1 is expressed in a subpopulation o...

  • Review
  • Open Access
35 Citations
13,291 Views
19 Pages

Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy

  • Maria Galuppo,
  • Sabrina Giacoppo,
  • Placido Bramanti and
  • Emanuela Mazzon

5 March 2014

Nephropathy, retinopathy cardiomyopathy and peripheral neuropathy are all recognized as important complications in about 50% of diabetes mellitus (DM) patients, mostly related to a poor glycemic control or to an improper management of this pathology....

  • Review
  • Open Access
15 Citations
7,916 Views
19 Pages

Diabetic peripheral neuropathy is a common complication of longstanding diabetes mellitus. These neuropathies can present in various forms, and with the increasing prevalence of diabetes mellitus, a subsequent increase in peripheral neuropathy cases...

  • Article
  • Open Access
6 Citations
10,404 Views
14 Pages

Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial—BLOSSOM

  • Martin Rakusa,
  • Iris Marolt,
  • Zorica Stevic,
  • Sandra Vuckovic Rebrina,
  • Tatjana Milenkovic and
  • Adam Stepien

18 July 2023

Introduction: Our trial (ClinicalTrials.gov Identifier: NCT04246619) evaluates the efficacy of two generic medications, pregabalin and duloxetine, for treating pain in PDPN patients. Methods: The patients were randomised either into the pregabalin (9...

  • Article
  • Open Access
5 Citations
3,177 Views
13 Pages

19 August 2022

Despite the worldwide prevalence and severe complications of type 2 diabetes mellitus (T2DM), the pathophysiological mechanisms underlying the development of diabetic polyneuropathy (DPN) are poorly understood. Beyond strict control of glucose levels...

  • Review
  • Open Access
10 Citations
5,463 Views
29 Pages

Recent Advances in Biomolecular Patho-Mechanistic Pathways behind the Development and Progression of Diabetic Neuropathy

  • Yashumati Ratan,
  • Aishwarya Rajput,
  • Ashutosh Pareek,
  • Aaushi Pareek,
  • Ranjeet Kaur,
  • Sonia Sonia,
  • Rahul Kumar and
  • Gurjit Singh

Diabetic neuropathy (DN) is a neurodegenerative disorder that is primarily characterized by distal sensory loss, reduced mobility, and foot ulcers that may potentially lead to amputation. The multifaceted etiology of DN is linked to a range of inflam...

  • Review
  • Open Access
55 Citations
7,748 Views
12 Pages

A Review of Topical and Systemic Vitamin Supplementation in Ocular Surface Diseases

  • Paolo Fogagnolo,
  • Stefano De Cilla’,
  • Micol Alkabes,
  • Pierfilippo Sabella and
  • Luca Rossetti

10 June 2021

In the homeostasis of the ocular surface, vitamins play a critical role in regulating inflammatory responses and promoting cell differentiation, development and correct function. Systemic vitamin supplementation has been available for many decades; i...

of 3